Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
MiSalud Raises $5M to Launch a Personalized Digital Health and Wellness Platform for the Underserved US Hispanic Community
MiSalud Inc. announced raising $5M and launching the beta version of their digital health platform. […]
Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline and Expand Single Cell Analysis Drug Development Platform
Immunitas Therapeutics (“Immunitas”), a single cell genomics-based therapeutics company, today announced the completion of a $58 […]
Ultromics Raises $33M in Series B Funding to Help Transform Cardiac Disease Treatment
Ultromics, a leader in AI enabled cardiovascular imaging solutions, announced today that it has raised […]
Musculoskeletal (MSK) Funding Opens
Funding has been created to support Integrated Care Systems (ICSs) who have an active interest […]
One Step Closer to Better Ocular Health: Zilia Secures $4 Million in Seed Funding
Zilia, a Quebec-based company developing medical technologies for the assessment of biomarkers in the eye, announced […]
The Biotech Market: Why Investors Should Take Interest
As the biotech industry continues to reach new heights, Maxim Manturov, Head of Investment Research at Freedom Finance […]
Aardvark Therapeutics, Inc., Completes $29m Series B Funding Led by Sorrento Therapeutics and Including Existing Investors and the Foundation for Prader-Willi Research
Aardvark Therapeutics, Inc., a clinical stage biopharmaceutical company focused on developing and commercializing novel small […]
4D Biomaterials Completes £1.6m ($2.2m) Seed Round
4D Biomaterials has just completed a £1.6m ($2.2m) seed investment round led by DSW Ventures […]
Wellbeing Platform 87% Raises £1.6million in Funding in Just Two Weeks
Leading workplace wellbeing platform 87% has raised £1.6 million in seed funding to accelerate its […]
Juno Medical Raises $5.4M in Seed Financing to Reimagine Primary Care for the 99%
Juno Medical, the modern doctor’s office that’s designed for the 99%, today announces $5.4 million in seed […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more